Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

8.20

+0.04 (0.49%)

Sep 18, 2026, 4:00 PM EDT - Market closed

Xeris Biopharma Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,495	1,303	505	325	181	365
Market Cap Growth	20.71%	157.72%	55.70%	79.47%	-50.50%	-
Enterprise Value	1,663	1,469	707	487	226	360
Last Close Price	8.20	7.85	3.39	2.35	1.33	2.93

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	2351.09	-	-	-	-
Forward PE	48.24	64.50	-	-	-	-
PS Ratio	4.46	4.46	2.49	1.98	1.64	7.37
PB Ratio	-	95.15	-17.07	-47.86	4.00	3.84
P/FCF Ratio	26.86	46.64	-	-	-	-
P/OCF Ratio	26.41	45.50	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.96	5.03	3.48	2.97	2.05	7.26
EV/EBITDA Ratio	34.09	39.64	-	-	-	-
EV/EBIT Ratio	45.44	58.99	-	-	-	-
EV/FCF Ratio	29.87	52.58	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-29.73	18.85	-9.17	-33.79	4.38	0.93
Debt / EBITDA Ratio	5.10	5.73	-	-	-	-
Debt / FCF Ratio	5.20	9.24	-	-	-	-
Net Debt / Equity Ratio	-17.23	10.74	-6.75	-23.11	1.68	-0.15
Net Debt / EBITDA Ratio	3.44	3.97	-9.26	-4.95	-1.09	0.14
Net Debt / FCF Ratio	3.01	5.27	-5.28	-3.18	-0.74	0.15
Asset Turnover	0.90	0.83	0.63	0.49	0.34	0.21
Inventory Turnover	0.61	0.73	0.85	0.90	1.06	1.01
Quick Ratio	0.95	1.48	1.12	1.17	2.08	1.52
Current Ratio	1.45	2.19	1.67	1.64	2.54	1.80
Return on Equity (ROE)	-	-	-	-324.20%	-134.83%	-190.28%
Return on Assets (ROA)	6.13%	4.40%	-6.51%	-8.25%	-15.78%	-28.45%
Return on Capital Employed (ROCE)	16.50%	9.10%	-15.10%	-19.40%	-30.20%	-46.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-1.15%	0.04%	-10.85%	-19.18%	-52.34%	-33.59%
FCF Yield	3.72%	2.14%	-7.49%	-15.18%	-57.18%	-26.44%
Buyback Yield / Dilution	-10.29%	-17.69%	-6.61%	-1.51%	-71.62%	-85.32%

SEC Filings: 10-K · 10-Q